Back to results
US 2025/0049859 A1Published application
Compositions and methods for activating nk cells
AssigneeThe Regents of the University of California
InventorAnahid Jewett
Life of this patent
Estimating the term…
Abstract
The present application relates to methods of activating a NK cells in vitro, ex vivo, and/or in vivo by an osteoclast cell (OC) and/or a dendritic cell, and methods of treating disease using these activated NK cells.
Claims18
1-82. (canceled)
A method of activating a NK cell, comprising:
- treating the NK cell with IL-2 and anti-CD16 antibody;
- and
- culturing the treated NK cell in a medium comprising osteoclast cell (OC) cells, thereby activating the NK cell.
Dependencies are inferred from the claim text.